Skip to main content

Table 1 Patient characteristics

From: Expression, localisation and potential significance of aquaporins in benign and malignant human prostate tissue

 

n (%)

Patient data

Age (years; range)

66 (47–84)

Total number

61 (100%)

 Benign prostatic hyperplasia (BPH)

15 (24.6%)

 Low-risk PC (D’Amico)

16 (26.2%)

 Intermediate PC (D’Amico)

16 (26.2%)

 High-risk PC (D’Amico)

14 (23.0%)

PSA

  < 4 ng/ml

2 (3.3%)

 4-10 ng/ml

36 (59.0%)

 10-20 ng/ml

12 (19.7%)

  > 20 ng/ml

5 (8.2%)

 n/a

6 (9.8%)

ISUP (Gleason-Score)

 1 (6)

17 (27.9%)

 2 (7a)

14 (23.0%)

 3 (7b)

1 (1.6%)

 4 (8)

3 (4.9%)

 5 (9–10)

11 (18.0%)

 No cancer

15 (24.6%)

T-stage

 pT2a

7 (11.5%)

 pT2b

1 (1.6%)

 pT2c

28 (45.9%)

 pT3/4

10 (16.4%)

 No cancer

15 (24.6%)